• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霍奇金淋巴瘤治疗的晚期并发症

Late complications of Hodgkin's disease management.

作者信息

Young R C, Bookman M A, Longo D L

机构信息

Fox Chase Cancer Center, Philadelphia, PA 19111.

出版信息

J Natl Cancer Inst Monogr. 1990(10):55-60.

PMID:2189477
Abstract

In the past several decades, Hodgkin's disease has been transformed from a uniformly fatal illness to one that can be treated with the expectation of long-term remission or cure in the majority of patients. Because patients now survive for long periods after curative intervention, various complications have been identified. The spectrum of complications following curative therapy is quite diverse and includes immunologic, cardiovascular, pulmonary, thyroid, and gonadal dysfunction. In addition, second malignant neoplasms in the form of acute leukemia as well as secondary solid tumors have now been documented to occur with increased frequency in patients cured of Hodgkin's disease.

摘要

在过去几十年里,霍奇金淋巴瘤已从一种普遍致命的疾病转变为一种多数患者有望通过治疗实现长期缓解或治愈的疾病。由于患者在接受根治性干预后现在能存活很长时间,已发现了各种并发症。根治性治疗后的并发症范围相当广泛,包括免疫、心血管、肺部、甲状腺和性腺功能障碍。此外,现已证明,霍奇金淋巴瘤治愈患者中,急性白血病形式的第二原发性恶性肿瘤以及继发性实体瘤的发生频率有所增加。

相似文献

1
Late complications of Hodgkin's disease management.霍奇金淋巴瘤治疗的晚期并发症
J Natl Cancer Inst Monogr. 1990(10):55-60.
2
Nonmalignant complications of therapy for Hodgkin's disease.霍奇金病治疗的非恶性并发症
Hematol Oncol Clin North Am. 1989 Jun;3(2):331-43.
3
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.一项病例对照研究表明,接受霍奇金淋巴瘤联合治疗方案的患者发生急性白血病的风险显著高于单纯接受化疗的患者,且该风险与放疗范围、化疗类型及疗程相关。
Haematologica. 1998 Sep;83(9):812-23.
4
"Very late" relapses in Hodgkin's disease patients: a rare but real phenomenon.
Haematologica. 1992 Sep-Oct;77(5):435-7.
5
Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.接受四个周期多柔比星、博来霉素、长春花碱和达卡巴嗪治疗及辅助放疗的临床IA-IIA期非大包块型成人霍奇金淋巴瘤患者的长期事件:单机构15年随访
Clin Cancer Res. 2006 Nov 1;12(21):6487-93. doi: 10.1158/1078-0432.CCR-06-1420.
6
[Late treatment related complications of Hodgkin's disease].
Rev Prat. 1998 May 15;48(10):1092-7.
7
Late complications of therapy of Hodgkin's disease: prevention and management.霍奇金淋巴瘤治疗的晚期并发症:预防与管理
Curr Hematol Rep. 2004 Jan;3(1):27-33.
8
Concomitant illness in patients treated for Hodgkin's disease.接受霍奇金病治疗患者的伴发疾病
Cancer Treat Rev. 1986 Jun;13(2):77-111. doi: 10.1016/0305-7372(86)90015-0.
9
Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.儿童霍奇金病后继发的第二原发性恶性肿瘤:治疗及脾切除术作为危险因素
Med Pediatr Oncol. 1989;17(6):477-84.
10
[Acute myeloid leukemia after treatment of Hodgkin's disease].霍奇金淋巴瘤治疗后发生的急性髓系白血病
Rev Hosp Clin Fac Med Sao Paulo. 1989 Mar-Apr;44(2):87-90.

引用本文的文献

1
Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.在皇家马斯登医院接受治疗的霍奇金病患者中的第二原发性恶性肿瘤。
Br J Cancer. 1997;75(1):116-23. doi: 10.1038/bjc.1997.19.
2
Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.霍奇金淋巴瘤按治疗类型划分的第二原发性癌症风险:对英国国家淋巴瘤调查中2846例患者的分析
BMJ. 1992 May 2;304(6835):1137-43. doi: 10.1136/bmj.304.6835.1137.